Page last updated: 2024-10-25

deferiprone and Pain

deferiprone has been researched along with Pain in 5 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"In previous trials, the orally active iron chelator deferiprone (L1) has been associated with sporadic agranulocytosis, milder forms of neutropenia and other side-effects."3.70Safety profile of the oral iron chelator deferiprone: a multicentre study. ( Cohen, AR; Dipalma, A; Galanello, R; Piga, A; Tricta, F; Vullo, C, 2000)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inati, A2
Khoriaty, E1
Musallam, KM1
Taher, AT1
Adhikari, D1
Cohen, AR1
Galanello, R1
Piga, A1
Dipalma, A1
Vullo, C1
Tricta, F1
Taher, A1
Sheikh-Taha, M1
Koussa, S1
Neeman, R1
Mourad, F1
Agarwal, MB1
Gupte, SS1
Viswanathan, C1
Vasandani, D1
Ramanathan, J1
Desai, N1
Puniyani, RR1
Chhablani, AT1

Trials

2 trials available for deferiprone and Pain

ArticleYear
Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
    European journal of haematology, 2001, Volume: 67, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Deferiprone; De

2001
Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial.
    British journal of haematology, 1992, Volume: 82, Issue:2

    Topics: Adolescent; Adult; beta-Thalassemia; Child; Deferiprone; Deferoxamine; Humans; Iron; Iron Chelating

1992

Other Studies

3 other studies available for deferiprone and Pain

ArticleYear
Iron chelation therapy for patients with sickle cell disease and iron overload.
    American journal of hematology, 2010, Volume: 85, Issue:10

    Topics: Administration, Oral; Anemia, Sickle Cell; Benzoates; Chelation Therapy; Child; Deferasirox; Deferip

2010
Deferiprone in iron overload.
    The New England journal of medicine, 1995, Aug-31, Volume: 333, Issue:9

    Topics: Deferiprone; Gastrointestinal Diseases; Humans; Iron Chelating Agents; Joint Diseases; Neutropenia;

1995
Safety profile of the oral iron chelator deferiprone: a multicentre study.
    British journal of haematology, 2000, Volume: 108, Issue:2

    Topics: Agranulocytosis; Alanine Transaminase; beta-Thalassemia; Deferiprone; Gastrointestinal Diseases; Hum

2000